Study of the Fixation of Various Vectors in PET/CT in Patients With a With Lung Cancer Before and During of CRT or RT
NCT01261585 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 5
Last updated 2010-12-16
Summary
Study of the modification of the fixation(binding) of Fluoro-2-deoxy-D-glucose (FDG), fluoro-misonidazole (FMISO) and 3'deoxy-3-fluoro-thymidine deoxy-3-fluoro-thymidine (FLT) measured in tomography by broadcast(emission,issue) of positrons (PET) at patients before and in the course of exclusive radiotherapy or concomitant radiochemotherapy for primitive bronchial cancer.
This protocle allows to study the simultaneous variations of the metabolism, the hypoxie and the cellular proliferation by PET SCAN at 5 patients reached(affected) by a primitive bronchial cancer in the course of exclusive radiotherapy for primitive bronchial cancer not small cell lung.
The investigators are also going to study several scenarii of optimization of the radiotherapy according to the variations of the tumoral metabolism, the hypoxie and the cellular proliferation measured in the course of radiotherapy (theoretical study on console using the scanner and the various examinations).
Conditions
- Bronchial Neoplasms
- Carcinoma, Non-Small-Cell Lung
Sponsors & Collaborators
-
Centre Henri Becquerel
lead OTHER
Principal Investigators
-
GUERNOU Mohamed, MD · CHBecquerel
-
VERA Pierre, MD phD · CHBecquerel
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2008-12-31
- Primary Completion
- 2009-11-30
- Completion
- 2009-12-31
Countries
- France
Study Locations
More Related Trials
-
The Utility of FDG-PET for Radiation Treatment in NSCLC
NCT00385164 ·Status: UNKNOWN
-
Positron Emission Tomography/Computed Tomography Scanning Before Surgery in Patients With Non-Small Cell Lung Cancer, Colorectal Cancer, Breast Cancer, Esophageal Cancer, or Head and Neck Cancer
NCT01254591 ·Status: UNKNOWN ·Phase: NA
-
Radiotherapy Planning Based on Positron Emission Tomography With Fluoro-deoxyglucose For Advanced NSCLC
NCT00697333 ·Status: UNKNOWN ·Phase: PHASE2
-
Benefits Study of Respiratory-gated PET Acquisition in Lung Disease
NCT01812031 ·Status: COMPLETED ·Phase: NA
-
68Ga-BNU-PSMA PET/CT in Patients With Various Types of Cancer
NCT04525612 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Dynamic Whole Body Positron Emission Tomography/Computed Tomography Imaging
NCT04017104 ·Status: UNKNOWN
-
Fluorine-18-α-Methyltyrosine Positron Emission Tomography (18F-FMT PET) for Therapy Response in Lung Cancer
NCT00826033 ·Status: COMPLETED
-
Positron Emission Tomography - Computed Tomography (PET-CT) Cetuximab Project
NCT00828620 ·Status: TERMINATED
-
Tumor Metabolism of Lung Cancer in Patients Who Underwent Percutaneous Radiation Measured With F-18-FDG-PET
NCT00180154 ·Status: COMPLETED
-
Influence of PET/CT Radiomic Features on the Outcome of Lung Cancer Patients
NCT03648151 ·Status: COMPLETED
-
Positron Emission Tomography for Detecting Non-small Cell Lung Cancer
NCT00004138 ·Status: COMPLETED ·Phase: NA
-
Follow-up of Patients With Curative-intent Surgical Resection for NSCLC
NCT00199615 ·Status: COMPLETED ·Phase: NA
-
PET-DECT for Staging and Imaged Based Radiotherapy Planning in Lung Cancer
NCT03146117 ·Status: TERMINATED
-
Positron Emission Tomography and Computed Tomography in Guiding Radiation Therapy for Stage III Non-small Cell Lung Cancer
NCT01507428 ·Status: COMPLETED ·Phase: PHASE2
-
An International Study on the Use of PET/CT in Radiotherapy Planning in Low and Middle Income Countries
NCT02247713 ·Status: UNKNOWN
-
Imaging of T-cell Activation With [18F]F-AraG in Advanced Non Small Cell Lung Cancer
NCT04726215 ·Status: UNKNOWN ·Phase: PHASE2
-
Fludeoxyglucose F18 Positron Emission Tomography Imaging In Assessing Patients Before and After Treatment for Locally Advanced Non-Small Cell Lung Cancer
NCT00083083 ·Status: UNKNOWN ·Phase: PHASE2
-
68Ga-PFA2 PET Imaging for the Diagnosis of Annexin A2-Positive Tumors
NCT07331532 ·Status: RECRUITING
-
Comparative Study of the Hypoxia Measured in FAZA and F-miso PET/CT Scan in Patients With Non-small Cell Lung Cancer
NCT02490696 ·Status: COMPLETED ·Phase: PHASE2
-
PET Response During Chemoradiation of Lung Cancer
NCT02315053 ·Status: COMPLETED ·Phase: NA
-
An Efficacy and Safety Study to Assess [18F]-ML-10 in Detecting Response of Tumors to Chemotherapy and Radiation
NCT01260480 ·Status: UNKNOWN ·Phase: PHASE2
-
18F-FDG and 68Ga-FAPI PET/CT in Lung Adenocarcinoma
NCT04588064 ·Status: COMPLETED ·Phase: NA
-
FLT-PET/DW-MRI for Detection of Brain Metastases and Early Therapy Evaluation in Patients With Small Cell Lung Cancer
NCT02995902 ·Status: COMPLETED ·Phase: NA
-
Role of FDG PET, Immune and Hypoxic Marker in NSCLC
NCT02519062 ·Status: COMPLETED
-
Fluorine-18-α-Methyltyrosine Positron Emission Tomography for Diagnosis and Staging of Lung Cancer
NCT00464282 ·Status: COMPLETED